---
title: A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data
nct_id: NCT06877884
overall_status: RECRUITING
sponsor: N-Power Medicine
study_type: OBSERVATIONAL
primary_condition: Cancer
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT06877884.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06877884"
ct_last_update_post_date: 2025-10-20
last_seen_at: "2026-05-12T07:29:11.813Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data

**Official Title:** A Prospective Registry for Collecting Standardized, Routine Care Data to Characterize Patients, Treatment Patterns, Safety and Treatment Effectiveness in Adult Oncology Patients

**NCT ID:** [NCT06877884](https://clinicaltrials.gov/study/NCT06877884)

## Key Facts

- **Status:** RECRUITING
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 20000
- **Lead Sponsor:** N-Power Medicine
- **Conditions:** Cancer
- **Start Date:** 2022-08-01
- **Completion Date:** 2099-01
- **CT.gov Last Update:** 2025-10-20

## Brief Summary

This is an observational registry for patients at participating oncology centers. The data collection includes but is not limited to baseline variables, treatments given and outcome data. Patient surveys are also included. The aim of the study is to generate rich and standardized data for patients and to help enable more patients participate in clinical trials and contribute to research and development.

## Detailed Description

This is an observational registry for patients at participating oncology centers. The data collection includes but is not limited to baseline variables, treatments given and outcome data. Patient surveys are also included. The aim of the study is to generate rich and standardized data for patients and to help enable more patients participate in clinical trials and contribute to research and development.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 120 Years
- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

Be a patient at a site (oncology) participating in the Registry Be at least 18 years old Be able and willing to provide signed informed consent

Exclusion Criteria:

Prisoners/imprisonment at time of screening for eligibility Patients who cannot consent without utilization of a legally authorized representative
```

## Primary Outcomes

- **Treatment Effectiveness - Time to treatment discontinuation** _(time frame: This is an open-ended registry where data will be collected, analysed and presented regularly over time.)_ — Effectiveness outcomes of treatments used in routine clinical care (such as for instance time to treatment discontinuation ) will be captured

## Locations (7)

- Pacific Cancer Care, Monterey, California, United States — _RECRUITING_
- Bayhealth Cancer Center-Kent, Dover, Delaware, United States — _RECRUITING_
- Bayhealth Cancer Center- Sussex, Milford, Delaware, United States — _RECRUITING_
- Northwest Oncology & Hematology, Elk Grove Village, Illinois, United States — _RECRUITING_
- New Mexico Oncology Hematology Consultants, Albuquerque, New Mexico, United States — _RECRUITING_
- Lankenau Medical Center, Paoli, Pennsylvania, United States — _RECRUITING_
- Oncology Consultants, P.A., Houston, Texas, United States — _RECRUITING_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.pacific cancer care|monterey|california|united states` — added _(2026-05-12)_
- `locations.bayhealth cancer center-kent|dover|delaware|united states` — added _(2026-05-12)_
- `locations.bayhealth cancer center- sussex|milford|delaware|united states` — added _(2026-05-12)_
- `locations.northwest oncology & hematology|elk grove village|illinois|united states` — added _(2026-05-12)_
- `locations.new mexico oncology hematology consultants|albuquerque|new mexico|united states` — added _(2026-05-12)_
- `locations.lankenau medical center|paoli|pennsylvania|united states` — added _(2026-05-12)_
- `locations.oncology consultants, p.a.|houston|texas|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT06877884.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT06877884*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*